Gyre Therapeutics (GYRE) Analyst & Key Data

Analyst Consensus

Buy1 analysts

Buy

Updated Sep 12, 2026

Total Analysts1

Buy

1

Ratings

Updated Sep 12, 2026

Overall Rating

C

DCF Score1.0 / 5

Debt / Equity Score4.0 / 5

Price / Book Score2.0 / 5

Price / Earnings Score1.0 / 5

ROA Score1.0 / 5

ROE Score1.0 / 5

Valuation

Current Stock Price

$6.73

Median Target+137.74%

$16.00

Potential upside vs current price

DCF Value-110.15%

-$0.68

Potential downside vs current price

Current Stock Price

$6.73

Median Target+137.74%

$16.00

Potential upside vs current price

DCF Value-110.15%

-$0.68

Potential downside vs current price

Analyst Consensus

Buy1 analysts

Buy

Updated Sep 12, 2026

Total Analysts1

Buy

1

Ratings

Updated Sep 12, 2026

Overall Rating

C

DCF Score1.0 / 5

Debt / Equity Score4.0 / 5

Price / Book Score2.0 / 5

Price / Earnings Score1.0 / 5

ROA Score1.0 / 5

ROE Score1.0 / 5

Valuation

Current Stock Price

$6.73

Median Target+137.74%

$16.00

Potential upside vs current price

DCF Value-110.15%

-$0.68

Potential downside vs current price

Current Stock Price

$6.73

Median Target+137.74%

$16.00

Potential upside vs current price

DCF Value-110.15%

-$0.68

Potential downside vs current price

Gyre Therapeutics, Inc.